Análisis de Costo Efectividad del Contacto Piel a Piel al Nacimiento, Temprano vs Inmediato, en la Morbilidad Neonatal de Recién Nacidos de Bajo Riesgo.

Autor: Agudelo SI; Pediatra y Perinatologo, Escuela de Graduados, Universidad CES, Medellín, Colombia; Jefe Departamento de Pediatría, Universidad de La Sabana, Chía, Colombia. Electronic address: sergioagpe@unisabana.edu.co., Gamboa OA; Facultad de Medicina, Universidad de La Sabana, Chía, Colombia., Molina CF; Ciencias de La Salud, Escuela de Graduados, Universidad CES, Medellín, Colombia.
Jazyk: angličtina
Zdroj: Value in health regional issues [Value Health Reg Issues] 2022 Jul; Vol. 30, pp. 100-108. Date of Electronic Publication: 2022 Mar 22.
DOI: 10.1016/j.vhri.2022.01.002
Abstrakt: Objectives: This study aimed to evaluate the cost-effectiveness of immediate skin-to-skin contact compared with early skin-to-skin contact in the prevalent neonatal morbidity of the low-risk newborn in Colombia.
Methods: A cost-effectiveness analysis was conducted. The perspective of the third payer (health system) was used, and the time horizon was the first month of life. Low-risk term infants were included at birth. The cost estimate was obtained from an expert consensus and a retrospective cohort of neonates hospitalized in a neonatal unit. The effectiveness of the interventions was obtained from a clinical trial and was defined as an avoided case of hospitalization. A decision tree was built, and the incremental cost-effectiveness ratio was calculated. Deterministic and probabilistic sensitivity analyses of the effects and costs were performed.
Results: Early skin-to-skin contact was a dominated intervention. In the probabilistic sensitivity analyses, early skin-to-skin contact was not an option to choose in any scenario and it was dominated in 68% of the simulations.
Conclusions: The findings suggest that early skin-to-skin contact is a dominated intervention. From an economic perspective, immediate skin-to-skin contact is a desired intervention for the prevention of prevalent diseases of the low-risk newborn at birth.
(Copyright © 2022 International Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: